Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: ISRCTN30877831. We help you review the study, but cannot decide medical eligibility.
Not recruitingISRCTN30877831
Addition of eicosapentaenoic acid to maintenance anti-depressant therapy in diabetes people with major depressive disorder: a study
This study is not recruiting in the Netherlands. It focuses on depression.
Depression, Mental healthOtherOver 18 Years
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- VU University Medical Center, EMGO-Institute (The Netherlands)
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- Netherlands
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN30877831
- Official title
- Addition of eicosapentaenoic acid to maintenance anti-depressant therapy in diabetes patients with major depressive disorder: a double-blind, placebo-controlled pilot study
Recruitment & locations
Not recruitingNetherlands
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is VU University Medical Center, EMGO-Institute (The Netherlands), a hospital or academic medical center.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not recruitingISRCTN68246470
(Cost)effectiveness of a cognitive group prevention module for recurrent depression
This study is not recruiting. It focuses on depression and currently lists study information in the Netherlands.
Not recruitingISRCTN23246262
A comparison of the efficacy and the safety of venlafaxine versus nortriptyline in the treatment of depressed elderly inpatients
This study is not recruiting in the Netherlands. It focuses on Depression.
Not recruitingISRCTN64428072
A study on the safety, tolerability, and effects of GM-2505
This study is not recruiting in the Netherlands. It focuses on Depression.